Venous Occlusion
13
3
5
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
7.7%
1 terminated out of 13 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
167%
5 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
WRAP North America
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
Evaluation of the Surfacer System Approach to Central Venous Access
The Merit WRAPSODY™ Endovascular Stent Graft
Non Contrast MRI in Lower Extremity
The Merit WRAPSODY Central Feasibility Study
Venous Occlusion and Limb Swelling
Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator